Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ACTIQ (fentanyl)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 04 September 2002
  • Documents : 1
  • History
Listen Listen
Add to my selection
    Quote this publication
    Share
    Share on
    Facebook share - facebook.com - new window
    Tweeter share - Partager sur Twitter - twitter.com - new window
    LinkedIn share - linkedin.com - new window
    Print

    ACTIQ (fentanyl)

    Opinions on drugs - Posted on Sep 04 2002 - Updated on Aug 14 2006

    Reason for request

    Inscription collectivités

    Documents

    • Avis_médicament_ct021159.pdf Xvox

    Follow us :

    • Twitter (nouvelle fenêtre)
    • Facebook (nouvelle fenêtre)
    • Youtube (nouvelle fenêtre)
    • LinkedIn (nouvelle fenêtre)
    Haute Autorité de Santé
    Advancing quality in the fields of health and social care services
    • Eunetha.eu
    • Pasq.eu
    • All our publications by topic and type
    • Opinions on medicines
    • Opinions on medical devices
    • INAHTA briefs
    • Français
    • English
    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
    sRnjNBpgPNh6P39F